Basit öğe kaydını göster

dc.contributor.authorSeida, İsa
dc.contributor.authorSeida, Ravend
dc.contributor.authorElsalti, Abdulrahman
dc.contributor.authorMahroum, Naim
dc.date.accessioned2023-03-10T11:37:44Z
dc.date.available2023-03-10T11:37:44Z
dc.date.issued2023en_US
dc.identifier.citationSeida, İ., Seida, R., Elsalti, A. ve Mahroum, N. (2023). Vaccines and autoimmunity—From side effects to ASIA syndrome. Medicina (Lithuania), 59(2). https://dx.doi.org/10.3390/medicina59020364en_US
dc.identifier.issn1010-660X
dc.identifier.issn1648-9144
dc.identifier.urihttps://dx.doi.org/10.3390/medicina59020364
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10610
dc.description.abstractSince vaccines are in fact manufactured chemical compounds such as drugs, the appearance of side effects following their use is not surprising. Similarly, as the main goal of vaccines is to stimulate the immune system bringing out the production of protective antibodies, autoimmune-related side effects as a consequence of increased immune activity do not seem irrational. Fortunately, the rate of such side effects is low; however, the importance of reporting adverse events following vaccinations, understanding the mechanisms behind their appearance, making early diagnosis, and appropriate treatment cannot be overemphasized. In fact, autoimmune-related side effects of vaccines, particularly those based on adjuvants, were reported long before the introduction of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Nevertheless, ASIA gathered and united the side effects of vaccines under one title, a step which helped organize the research and call for better immune stimulators than adjuvants. New technologies and methods of making vaccines were clearly noticed during the pandemic of COVID-19 after the introduction of mRNA-based vaccines. In our current paper, we introduce the notion of side effects to vaccines, particularly those of autoimmune nature, the mechanisms of ASIA, and the main vaccines linked with the syndrome including the recent COVID-19 vaccines. The transition from side effects to ASIA is the main idea behind our work.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectASIAen_US
dc.subjectAdjuvanten_US
dc.subjectHepatitis B Vaccineen_US
dc.subjectInfluenza Vaccineen_US
dc.subjectCOVID-19en_US
dc.titleVaccines and autoimmunity—From side effects to ASIA syndromeen_US
dc.typereviewen_US
dc.relation.ispartofMedicina (Lithuania)en_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-4130-3978en_US
dc.authorid0000-0002-7919-1326en_US
dc.identifier.volume59en_US
dc.identifier.issue2en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.3390/medicina59020364en_US
dc.institutionauthorSeida, İsa
dc.institutionauthorSeida, Ravend
dc.institutionauthorElsalti, Abdulrahman
dc.institutionauthorMahroum, Naim
dc.identifier.wosqualityQ3en_US
dc.identifier.wos000940588100001en_US
dc.identifier.scopus2-s2.0-85148853686en_US
dc.identifier.pmid36837564en_US
dc.identifier.scopusqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess